Milestone Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights

Milestone Pharmaceuticals Inc share price today is $1.4, up -20%. The stock opened at $1.61 against the previous close of $1.7, with an intraday high of $1.61 and low of $1.355.

Milestone Pharmaceuticals Inc Share Price Chart

Milestone Pharmaceuticals Inc

us-stock
To Invest in {{usstockname}}
us-stock

Milestone Pharmaceuticals Inc Share Price Performance

$1.4 -0.2(-20%) MIST at 23 Mar 2026 02:17 PM Biotechnology
Lowest Today 1.355
Highest Today 1.61
Today’s Open 1.61
Prev. Close 1.7
52 Week High 3.06
52 Week Low 0.63
Day’s Range: Low 1.355 High 1.61
52-Week Range: Low 0.63 High 3.06
1 day return -
1 Week return -19.28
1 month return -19.28
3 month return -34.45
6 month return -32.16
1 year return -33.33
3 year return -58.28
5 year return -81.26
10 year return -

Milestone Pharmaceuticals Inc Institutional Holdings

Propel Bio Management LLC 4.84

Morgan Stanley - Brokerage Accounts 3.49

Adage Capital Partners Gp LLC 3.30

RTW INVESTMENTS, LLC 2.94

Marshall Wace Asset Management Ltd 1.95

Two Sigma Investments LLC 1.78

Simplify Asset Management Inc. 1.77

Simplify Propel Opportunities ETF 1.77

Jane Street Group LLC 1.28

Pathstone Holdings LLC 1.19

The Toronto-Dominion Bank 0.88

Boxer Capital Management, LLC 0.78

Stonepine Capital Management Llc 0.78

Lion Point Capital, LP 0.77

Susquehanna International Group, LLP 0.76

Two Sigma Advisers, LLC 0.73

Millennium Management LLC 0.47

UBS Group AG 0.47

The Goldman Sachs Group Inc 0.42

Citadel Advisors Llc 0.41

Aptus Capital Advisors, LLC 0.31

Biotech Growth Ord 0.17

Fidelity Nasdaq Composite Index 0.09

Invesco NASDAQ Future Gen 200 ETF 0.03

State Street® SPDR® S&P® Intl Sm Cp ETF 0.03

Blackstone Alternative Multi-Strategy I 0.00

Milestone Pharmaceuticals Inc Market Status

Strong Buy: 0

Buy: 2

Hold: 2

Sell: 0

Strong Sell: 0

Milestone Pharmaceuticals Inc Fundamentals

Market Cap 115.83 M

PB Ratio 7.0833

PE Ratio 0.0

Enterprise Value 119.41 M

Total Assets 113.56 M

Volume 5775496

Milestone Pharmaceuticals Inc Company Financials

Annual Revenue FY23:4500000 4.5M, FY22:5000000 5.0M, FY21:15000000 15.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:5000000 5.0M, FY21:15000000 15.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-59251000 -59.3M, FY22:-57134000 -57.1M, FY21:-42633000 -42.6M, FY20:-49967000 -50.0M, FY19:-55229000 -55.2M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-24999 -0.0M, Q2/2025:-28000 -0.0M, Q1/2025:-27000 -0.0M, Q3/2024:null 0.0M, Q2/2024:-26000 -0.0M

Quarterly Net worth Q3/2025:-11922000 -11.9M, Q2/2025:-12966000 -13.0M, Q1/2025:-20761000 -20.8M, Q3/2024:-9439000 -9.4M, Q2/2024:-9363000 -9.4M

About Milestone Pharmaceuticals Inc & investment objective

Company Information Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.

Organisation Biotechnology

Employees 33

Industry Biotechnology

CEO Mr. Joseph G. Oliveto M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Milestone Pharmaceuticals Inc FAQs

What is the share price of Milestone Pharmaceuticals Inc today?

The current share price of Milestone Pharmaceuticals Inc is $1.4.

Can I buy Milestone Pharmaceuticals Inc shares in India?

Yes, Indian investors can buy Milestone Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Milestone Pharmaceuticals Inc shares in India?

You can easily invest in Milestone Pharmaceuticals Inc shares from India by:

Can I buy fractional shares of Milestone Pharmaceuticals Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Milestone Pharmaceuticals Inc?

Milestone Pharmaceuticals Inc has a market cap of $115.83 M.

In which sector does Milestone Pharmaceuticals Inc belong?

Milestone Pharmaceuticals Inc operates in the Biotechnology sector.

What documents are required to invest in Milestone Pharmaceuticals Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Milestone Pharmaceuticals Inc?

The PE ratio of Milestone Pharmaceuticals Inc is N/A and the PB ratio is 7.08.